Literature DB >> 10897360

Evaluation of a 200-kDa amastigote-specific antigen of L. donovani by enzyme-linked immunosorbent assay (ELISA) for the diagnosis of visceral leishmaniasis.

P Kaul1, N Malla, S Kaur, R C Mahajan, N K Ganguly.   

Abstract

A purified 200-kDa antigenic fraction from Leishmania donovani axenic amastigotes was evaluated by ELISA for the detection of antibody response in visceral leishmaniasis (VL) patients, post kala-azar dermal leishmaniasis (PKDL) patients and controls, for the diagnosis of visceral leishmaniasis. A positive antibody response to the 200-kDa amastigote fraction and to Leishmania amastigote soluble antigen (LASA) was found in 29 (96.6%) and 30 ((100%) confirmed VL patients, respectively, by the use of ELISA. However, only 1 (10%) out of 10 PKDL patients had detectable antibody response to 200-kDa fraction while all the 10 (100%) PKDL patients exhibited an immune response to LASA. Therefore, use of the 200-kDa antigenic fraction for the detection of antibody response in an ELISA follow-up (post treatment) of VL patients may have prognostic significance, and it may also be useful for differentiating active VL and PKDL.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10897360     DOI: 10.1016/s0035-9203(00)90264-5

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  7 in total

1.  ELISA with recombinant rKRP42 antigen using urine samples: a tool for predicting clinical visceral leishmaniasis cases and its outbreak.

Authors:  Mohammad Zahidul Islam; Makoto Itoh; Md Anwar Ul Islam; A R M Saifuddin Ekram; Md Ajijur Rahman; Hidekazu Takagi; Atsuhide Takesue; Yoshihisa Hashiguchi; Eisaku Kimura
Journal:  Am J Trop Med Hyg       Date:  2012-08-06       Impact factor: 2.345

2.  Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis.

Authors:  Anil Kumar Jaiswal; Prashant Khare; Sumit Joshi; Pramod Kumar Kushawaha; Shyam Sundar; Anuradha Dube
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

3.  Significance of persistence of antibodies against Leishmania infantum in Sicilian patients affected by acute visceral leishmaniasis.

Authors:  Pasquale Mansueto; Ilenia Pepe; Aurelio Seidita; Francesca Scozzari; Giustina Vitale; Francesco Arcoleo; Inglese Elvira; Enrico Cillari; Giovam Battista Rini; Nicola Napoli; Salvatore Di Rosa; Serafino Mansueto; Gaetana Di Fede
Journal:  Clin Exp Med       Date:  2011-06-29       Impact factor: 3.984

4.  Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.

Authors:  Samiran Saha; Tuhina Mazumdar; Khairul Anam; Rajesh Ravindran; Bibhas Bairagi; Bibhuti Saha; Ramapada Goswami; Netai Pramanik; Subhashis K Guha; Sourjya Kar; Dwijadas Banerjee; Nahid Ali
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

5.  Diagnosis of visceral leishmaniasis by enzyme-linked immunosorbent assay using urine samples.

Authors:  Mohammad Zahidul Islam; Makoto Itoh; S M Shamsuzzaman; Rusella Mirza; Farzana Matin; Iftikhar Ahmed; A K M Shamsuzzaman Choudhury; M Akram Hossain; Xu-Guang Qiu; Nilufar Begam; Masato Furuya; Judson L Leafasia; Yoshihisa Hashiguchi; Eisaku Kimura
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

6.  Leishmania donovani Secretory Mevalonate Kinase Regulates Host Immune Response and Facilitates Phagocytosis.

Authors:  Tanvir Bamra; Taj Shafi; Sushmita Das; Manjay Kumar; Manas Ranjan Dikhit; Ajay Kumar; Ashish Kumar; Kumar Abhishek; Krishna Pandey; Abhik Sen; Pradeep Das
Journal:  Front Cell Infect Microbiol       Date:  2021-04-26       Impact factor: 5.293

7.  Systematic review on antigens for serodiagnosis of visceral leishmaniasis, with a focus on East Africa.

Authors:  Vera Kühne; Zahra Rezaei; Paul Pitzinger; Philippe Büscher
Journal:  PLoS Negl Trop Dis       Date:  2019-08-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.